دورية أكاديمية
أعرض في EDS

Age and sex differences in cause-specific excess mortality and years of life lost associated with COVID-19 infection in the Swedish population.

التفاصيل البيبلوغرافية
العنوان: Age and sex differences in cause-specific excess mortality and years of life lost associated with COVID-19 infection in the Swedish population.
المؤلفون: Lundberg CE; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Food and Nutrition, and Sport Science, University of Gothenburg, Gothenburg, Sweden., Santosa A; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Björk J; Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, Faculty of Medicine, Lund University, Lund, Sweden.; Clinical Studies Sweden, Forum South, Skåne University Hospital, Lund, Sweden., Brandén M; Stockholm University Demography Unit (SUDA), Department of Sociology, Stockholm University Demography Unit, Stockholm University, Stockholm, Sweden.; Institute for Analytical Sociology, Linköping University, Norrköping, Sweden., Cronie O; Department of Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden., Lindgren M; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Medicine Geriatrics and Emergency Medicine, Sahlgrenska University Hospital Östra Hospital, Region Västra Götaland, Gothenburg, Sweden., Edqvist J; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Åberg M; School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Regionhälsan, Region Västra Götaland, Gothenburg, Sweden., Adiels M; School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Rosengren A; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Medicine Geriatrics and Emergency Medicine, Sahlgrenska University Hospital Östra Hospital, Region Västra Götaland, Gothenburg, Sweden.
المصدر: European journal of public health [Eur J Public Health] 2023 Oct 10; Vol. 33 (5), pp. 916-922.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9204966 Publication Model: Print Cited Medium: Internet ISSN: 1464-360X (Electronic) Linking ISSN: 11011262 NLM ISO Abbreviation: Eur J Public Health Subsets: MEDLINE
أسماء مطبوعة: Publication: Oxford : Oxford University Press
Original Publication: Stockholm, Sweden : Almqvist & Wiksell International, c1991-
مستخلص: Background: Estimating excess mortality and years of life lost (YLL) attributed to coronavirus disease 19 (COVID-19) infection provides a comprehensive picture of the mortality burden on society. We aimed to estimate the impact of the COVID-19 pandemic on age- and sex-specific excess mortality and YLL in Sweden during the first 17 months of the pandemic.
Methods: In this population-based observational study, we calculated age- and sex-specific excess all-cause mortality and excess YLL during 2020 and the first 5 months of 2021 and cause-specific death [deaths from cardiovascular disease (CVD), cancer, other causes and deaths excluding COVID-19] in 2020 compared with an average baseline for 2017-19 in the whole Swedish population.
Results: COVID-19 deaths contributed 9.9% of total deaths (98 441 deaths, 960 305 YLL) in 2020, accounting for 75 151 YLL (7.7 YLL/death). There were 2672 (5.7%) and 1408 (3.0%) excess deaths, and 19 141 (3.8%) and 3596 (0.8%) excess YLL in men and women, respectively. Men aged 65-110 years and women aged 75-110 years were the greatest contributors. Fewer deaths and YLL from CVD, cancer and other causes were observed in 2020 compared with the baseline adjusted to the population size in 2020.
Conclusions: Compared with the baseline, excess mortality and YLL from all causes were experienced in Sweden during 2020, with a higher excess observed in men than in women, indicating that more men died at a younger age while more women died at older ages than expected. A notable reduction in deaths and YLL due to CVD suggests a displacement effect from CVD to COVID-19.
(© The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association.)
References: Lancet. 2021 Aug 14;398(10300):599-607. (PMID: 34332652)
Lancet Infect Dis. 2021 Apr;21(4):e74. (PMID: 32763192)
J Epidemiol Community Health. 2021 Aug;75(8):735-740. (PMID: 33468602)
BMJ. 2021 Jun 23;373:n1343. (PMID: 34162598)
J Epidemiol. 2021 Jan 5;31(1):90-92. (PMID: 33132284)
Gesundheitswesen. 2021 Sep;83(8-09):e41-e48. (PMID: 34496443)
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):. (PMID: 33446511)
J Epidemiol Community Health. 2021 Mar;75(3):213-223. (PMID: 33060194)
SSM Popul Health. 2021 Dec 17;17:101006. (PMID: 35005187)
Int J Epidemiol. 2022 Feb 18;51(1):35-53. (PMID: 34282450)
J Korean Med Sci. 2020 Aug 17;35(32):e300. (PMID: 32808515)
BMJ. 2021 May 19;373:n1137. (PMID: 34011491)
Viruses. 2021 Dec 03;13(12):. (PMID: 34960692)
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):297-306. (PMID: 33412822)
Eur J Public Health. 2021 Feb 1;31(1):17-22. (PMID: 33169145)
Am J Epidemiol. 2021 Aug 1;190(8):1510-1518. (PMID: 33710317)
Sci Rep. 2021 Feb 18;11(1):3504. (PMID: 33603008)
Aging Clin Exp Res. 2022 Feb;34(2):475-479. (PMID: 35006542)
J Am Coll Cardiol. 2022 Aug 9;80(6):631-640. (PMID: 35926937)
SSM Popul Health. 2022 Mar;17:101021. (PMID: 35018297)
SSM Popul Health. 2023 Jun;22:101377. (PMID: 36919136)
Int J Epidemiol. 2022 Dec 13;51(6):1722-1732. (PMID: 36331437)
Front Public Health. 2021 May 07;9:663259. (PMID: 34026717)
JAMA. 2020 Nov 24;324(20):2100-2102. (PMID: 33044514)
Lancet Reg Health Am. 2022 Jan;5:100093. (PMID: 34778864)
Euro Surveill. 2020 Jul;25(26):. (PMID: 32643601)
Lancet Reg Health Eur. 2021 Mar 17;4:100072. (PMID: 34557812)
Sci Rep. 2022 Jan 20;12(1):1077. (PMID: 35058508)
Lancet Healthy Longev. 2020 Nov;1(2):e80-e88. (PMID: 33521770)
Nat Commun. 2022 Jan 25;13(1):482. (PMID: 35079022)
Public Health. 2022 Feb;203:91-96. (PMID: 35033739)
Eur J Epidemiol. 2022 Oct;37(10):1025-1034. (PMID: 36127511)
J Epidemiol. 2021 Feb 5;31(2):152-156. (PMID: 33310986)
PLoS One. 2021 Sep 1;16(9):e0256835. (PMID: 34469474)
Lancet. 2022 Apr 16;399(10334):1513-1536. (PMID: 35279232)
معلومات مُعتمدة: 2021-0345 Swedish Heart and Lung Foundation; 2018-02527 Swedish Research Council; 2021-00304 Swedish Research Council for Health, Working Life and Welfare
تواريخ الأحداث: Date Created: 20230601 Latest Revision: 20231013
رمز التحديث: 20231013
مُعرف محوري في PubMed: PMC10567253
DOI: 10.1093/eurpub/ckad086
PMID: 37263601
قاعدة البيانات: MEDLINE
الوصف
تدمد:1464-360X
DOI:10.1093/eurpub/ckad086